Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation

American Journal of Infection Control

Volumn 43, Issue 11, 2015, Pages 1238-1243

  Bryce, Elizabeth ^a   Grant, Jennifer ^a   Scharf, Sydney ^a   Dempster, Linda ^b   Lau, Tim T Y ^b   Laing, Felicia ^b   Shajari, Salomeh ^b   Forrester, Leslie ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b VANCOUVER COASTAL HEALTH   (Canada)

Author keywords

Risk management; Vancomycin resistant enterococci

Indexed keywords

ANTIMICROBIAL STEWARDSHIP PROGRAM; ARTICLE; BACTEREMIA; BONE MARROW TRANSPLANT UNIT; BURN UNIT; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SURVEILLANCE; ENVIRONMENTAL CLEANING; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH PROGRAM; HOSPITAL BED UTILIZATION; HOSPITAL DEPARTMENT; HOSPITAL FINANCE; HOSPITAL INFECTION; HOSPITAL SUBDIVISIONS AND COMPONENTS; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PATIENT CARE; RISK MANAGEMENT; SOLID ORGAN TRANSPLANT UNIT; VANCOMYCIN RESISTANT ENTEROCOCCUS; CROSS INFECTION; DISEASE TRANSMISSION; DRUG UTILIZATION; GRAM-POSITIVE BACTERIAL INFECTIONS; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREVENTION AND CONTROL; PROCEDURES; STANDARDS; TRANSMISSION;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; DRUG UTILIZATION; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84946485362     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.06.003     Document Type: Article

References (16)

1. N.T. Mutters, V. Mersch-Sundermann, R. Mutters, C. Brandt, W. Schneider-Brachet, U. Frank, and et al. Control of the spread of vancomycin-resistant enterococci in hospitals Dtsch Arztebl Int 110 2013 725 731
2. W.C. Huskins, C.M. Huckabee, N.P. O'Grady, P. Murray, H. Kopetskie, L. Zimmer, and et al. Intervention to reduce transmission of resistant bacteria in intensive care N Engl J Med 364 2011 1407 1418
3. S.W. Aboelela, L. Saiman, P. Stone, F.D. Lowy, D. Quiros, and E. Larson Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organsims: a systematic review of the literature Am J Infect Control 34 2006 484 494
4. K.Y. Popiel, and M.A. Miller Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital Infect Control Hosp Epidemiol 35 2014 818 825
5. M. Pogorzelska, P.W. Stone, and E.L. Larson Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study Am J Infect Control 40 2012 696 700
6. M. Ofner-Agostini, B.L. Johnston, A.E. Simor, J. Embil, A. Matlow, M. Mulvey, and et al. Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005 Infect Control Hosp Epidemiol 29 2008 271 274
7. P. Gastmeier, C. Schröder, M. Behnke, E. Meyer, and C. Geffers Dramatic increase in vancomycin-resistant enterococci in Germany J Antimicrob Chemother 69 2014 1160 1164
8. N. Bourdon, M. Fines-Guyon, J.M. Thiolet, S. Maugat, B. Coignard, R. Leclercq, and et al. Changing trends in vancomycin-resistant enterococci in French Hospital, 2001-08 J Antimicrob Chemother 66 2011 713 721
9. E. Septimus, R.A. Weinstein, T.M. Perl, D.A. Goldmann, and D.S. Yokoe Approaches for preventing healthcare-associated infections: go long or go wide? Infect Control Hosp Epidemiol 35 Suppl 2014 S10 S14
10. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Satistics for Public Health, Version 3.03a. Available from: http://www.openepi.com. Updated 2015/05/04. Accessed June 6, 2015.
11. S. Raschka, L. Dempster, and E. Bryce Health economic evaluation of an infection prevention and control program: are quality and patient safety programs worth the investment? Am J Infect Control 41 2013 773 777
12. WHO Collaborating Centre for Drug Statistics Methodology. DDD: definition and general considerations. Available from: http://www.whocc.no/ddd/definition. Accessed March 31, 2015.
13. Provincial Infectious Diseases Advisory Committee (PIDAC) Review of literature for evidence-based best practices for VRE control. 2012. Available from: http://www.publichealthontario.ca/en/eRepository/PIDAC-IPC-VRE-Evidence-based-Review-2012-Eng.pdf. Accessed March 31, 2015.
14. Lam F, Johnstone J, Adomako K, Prematunge C, Robertson J, Egan C, Garber G. Vancomycin resistant enterococcus (VRE) rates in Ontario, Canada after the discontinuation of VRE screening and control practices by some hospitals: interim results. Abstract presented at: ID Week. 2014 Oct 8-12; Philadelphia [PA]. 2014.
15. C. Ho, A. Lau, K. Cimon, K. Farrah, and M. Gardam Screening, isolation and decolonization strategies for vancomycin-resistant enterococci or extended spectrum beta-lactamase-producing organisms: a systematic review of the clinical evidence and health services impact CADTH Technol Overv 3 2013 e3202
16. S. Dhar, D. Marchaim, R. Tansek, T. Chopra, A. Yousuf, A. Bhargava, and et al. Contact precautions: more is not necessarily better Infect Control Hosp Epidemiol 35 2014 213 221